Ignite Creation Date:
2024-05-06 @ 2:54 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04464213
Status:
UNKNOWN
Last Update Posted:
2022-10-21
First Post:
2020-07-07
Brief Title:
Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer
Sponsor:
Beijing Tongren Hospital
Organization:
Beijing Tongren Hospital
Study Overview
Official Title:
Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer
Status:
UNKNOWN
Status Verified Date:
2021-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designated to
1 investigate the tolerance and safety of treatment of Human placental mesenchymal stem cells gel on Human diabetic foot ulcer
2 learn the primary effectiveness of Human placental mesenchymal stem cells gel on Human diabetic food ulcer
3 study the pharmacokinetics of Human placental mesenchymal stem cells gel on Human diabetic food ulcer
1 investigate the tolerance and safety of treatment of Human placental mesenchymal stem cells gel on Human diabetic foot ulcer
2 learn the primary effectiveness of Human placental mesenchymal stem cells gel on Human diabetic food ulcer
3 study the pharmacokinetics of Human placental mesenchymal stem cells gel on Human diabetic food ulcer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None